Michael Tomsicek

Michael Tomsicek possesses extensive experience in financial leadership within the life sciences sector. Currently serving as an Independent Director and Audit Committee Chair at Milestone Pharmaceuticals, Inc. since April 2019, Tomsicek is also actively involved as an Independent Director at Acrivon Therapeutics, Inc. and a Board Member for Cimeio Therapeutics, both since late 2022. A member of the Board of Directors for Life Science Cares Boston since 2016, Tomsicek contributes to initiatives aimed at reducing poverty through resources from the life sciences industry. Previously, Tomsicek held key financial positions, including Chief Financial Officer at CRISPR Therapeutics, Abiomed, and Cubist Pharmaceuticals, where responsibilities spanned corporate finance leadership and operational oversight. Tomsicek's career includes roles at GE Healthcare and Motorola, focusing on commercial finance and business planning. Academically, Tomsicek earned an MBA from the Wisconsin School of Business and a Bachelor of Science in Industrial Engineering from the University of Wisconsin-Madison.